Department Of Biomedical Science 1

1. Public health impact of heatwave in Africa: an urgent call for action
2. Mortality trends in Kazakhstan: insights from a million of deaths from 2014 to 2022
3. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
4. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
5. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
6. Knowledge of cervical cancer, risk factors, and barriers to screening among reproductive women in Nigeria
7. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
8. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
9. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
10. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM_2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
11. Emerging nano-delivery systems for targeting mitochondria
12. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
13. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
14. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
15. Defining and unpacking the core concepts of pharmacology: A global initiative
16. Diphtheria outbreak in Nigeria: What do we know so far?
17. Evaluating student understanding of pharmacodynamics core concepts
18. Screening and Identification of Natural Compounds as Potential Inhibitors of Glutamate Racemase, an Emerging Drug Target of Food Pathogen E. coli O157:H7: An In-silico Approach to Combat Increasing Drug Resistance
19. Screening and Identification of Natural Compounds as Potential Inhibitors of Glutamate Racemase, an Emerging Drug Target of Food Pathogen E. coli O157:H7: An In-silico Approach to Combat Increasing Drug Resistance
20. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
21. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
22. Healthcare workers and monkeypox: The case for risk mitigation
23. The monkeypox virus: A public health challenge threatening Africa
24. Lipofection of single guide rna targeting mmp8 decreases proliferation and migration in lung adenocarcinoma cells
25. Lung development, repair and cancer: A study on the role of MMP20 gene in adenocarcinoma
26. The impact of cellular environment on in vitro drug screening
27. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
28. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
29. Combating diphtheria outbreak in Nigeria must not be ignored!
30. Savinase-functionalised oxidative drug-loaded nanocarriers enhance the treatment of solid colorectal tumours in a 3D cell culture model
31. Antiproliferative and cytotoxic activity of Geraniaceae plant extracts against five tumor cell lines
32. Investigating the Suitability of Mare’s Milk-Derived Exosomes as Potential Drug Carriers
33. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
34. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
35. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
36. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
37. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
38. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
39. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
40. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
41. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
42. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
43. Focused Modulation of Brain Activity: A Narrative Review
44. Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic Applications
45. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1